Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation

    Life-threatening cytomegalovirus infection (CMVI) has been reported even in patients with malignant lymphoma (ML) who have not received hematopoietic stem cell transplantation (w/o HSCT) but had been treated w...

    Kazuya Sato, Sho Igarashi, Nodoka Tsukada, Junki Inamura, Masayo Yamamoto in BMC Cancer (2022)

  2. No Access

    Article

    Iron-induced epigenetic abnormalities of mouse bone marrow through aberrant activation of aconitase and isocitrate dehydrogenase

    Iron overload remains a concern in myelodysplastic syndrome (MDS) patients. Iron chelation therapy (ICT) thus plays an integral role in the management of these patients. Moreover, ICT has been shown to prolong...

    Masayo Yamamoto, Hiroki Tanaka, Yasumichi Toki in International Journal of Hematology (2016)

  3. No Access

    Article

    Current therapeutic strategies for multiple myeloma

    The introduction of novel molecular targeting agents against multiple myeloma has dramatically and rapidly changed the therapeutic strategies for this incurable hematologic disease. Novel agents such as thalid...

    Yoshihiro Torimoto, Motohiro Shindo in International Journal of Clinical Oncology (2015)

  4. No Access

    Article

    Effectiveness of pazopanib for postoperative recurrence of granulocyte colony-stimulating factor-producing primary hepatic angiosarcoma

    A 38-year-old Japanese woman was referred to our hospital with complaints of fever, general fatigue, and upper abdominal discomfort. Computed tomography revealed a massive tumor in the right lobe of the liver,...

    Koji Sawada, Manabu Soma, Shunsuke Nakajima in International Cancer Conference Journal (2015)

  5. No Access

    Article

    Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group

    Following the introduction of rituximab, the long-term overall survival (OS) rate of advanced-stage follicular lymphoma (FL) cases was expected to improve after the introduction of rituximab: however, there is...

    Yasuo Hirayama, Kunihiko Ishitani, Shuithi Ota in International Journal of Hematology (2014)

  6. No Access

    Article

    A cancer of unknown primary showing positive immunoreactions for intestinal epithelial markers

    Cancer of unknown primary is defined in cases in which cancer cells are found in the body, but the place where the cells first started growing (the origin or primary site) cannot be determined. We herein prese...

    Mikihiro Fujiya, Yoshihiro Torimoto in International Cancer Conference Journal (2014)

  7. Article

    Open Access

    Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib

    Nilotinib is a second-generation tyrosine kinase inhibitor that exhibits significant efficacy as first- or second-line treatment in patients with chronic myeloid leukemia (CML). We conducted a multicenter Phas...

    Naoto Takahashi, Masatomo Miura, Jun Kuroki, Kinuko Mitani in Biomarker Research (2014)

  8. No Access

    Article

    Hepcidin production in response to iron is controlled by monocyte-derived humoral factors

    Hepcidin, which is mainly produced by the liver, is the key regulator in iron homeostasis. Hepcidin expression is up-regulated by iron loading in vivo, but the mechanism underlying this process is not complete...

    Yusuke Sasaki, Yasushi Shimonaka, Katsuya Ikuta in International Journal of Hematology (2014)

  9. No Access

    Article

    Ex vivo activation of angiogenic property in human peripheral blood-derived monocytes by thrombopoietin

    Human peripheral blood mononuclear cells (PB-MNCs) have angiogenic properties, which make them promising cells for use in angiogenic therapy approaches in regenerative medicine. To explore an efficient method ...

    Toru Kawamoto, Junpei Sasajima, Yoshiaki Sugiyama in International Journal of Hematology (2013)

  10. No Access

    Article

    A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group

    Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) comprises a group of heterogeneous lymphomas that do not fit any other identified PTCL-subgroup and show poor prognosis. To clarify clinical aspect...

    Yoshihiro Torimoto, Kazuya Sato, Katsuya Ikuta in International Journal of Hematology (2013)

  11. No Access

    Article

    Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

    Invasive fungal infection (IFI) causes morbidity and mortality among patients with hematological malignancies who receive cytotoxic chemotherapy or hematopoietic stem cell transplantation (HSCT). We evaluated ...

    Mitsutoshi Kurosawa, Masakatsu Yonezumi in International Journal of Hematology (2012)

  12. No Access

    Article

    Development of POEMS syndrome after an initial manifestation of solitary plasmacytoma

    A 44-year-old male was admitted for numbness in the left arm. CT showed a tumor impacting on the spinal cord with an adjacent thoracic vertebral osteosclerotic lesion. The histopathology of the tumor showed di...

    Motohiro Shindo, Kazuya Sato, Masayo Yamamoto in International Journal of Hematology (2011)

  13. No Access

    Article

    Loss of ABCB7 gene: pathogenesis of mitochondrial iron accumulation in erythroblasts in refractory anemia with ringed sideroblast with isodicentric (X)(q13)

    An isodicentric (X)(q13) (idicXq13) is a rare, acquired chromosomal abnormality originated by deletion of the long arm from Xq13 (Xq13-qter), and is found in female patients with hematological disorders involv...

    Kazuya Sato, Yoshihiro Torimoto, Takaaki Hosoki in International Journal of Hematology (2011)

  14. No Access

    Article

    Atypical Takayasu arteritis with solitary stenosis in the short segment of right axillary artery

    Takayasu arteritis is a rare, idiopathic, and chronic inflammatory large vessel vasculitis, involving mainly the aorta and its major branches. Takayasu arteritis predominantly affects women. The clinical prese...

    Katsuya Ikuta, Yoshihiro Torimoto, Motohiro Shindo in Rheumatology International (2010)

  15. No Access

    Article

    Current topics and perspectives on malignant lymphoma

    Yutaka Kohgo, Yoshihiro Torimoto in International Journal of Clinical Oncology (2009)

  16. No Access

    Article

    Body iron metabolism and pathophysiology of iron overload

    Iron is an essential metal for the body, while excess iron accumulation causes organ dysfunction through the production of reactive oxygen species. There is a sophisticated balance of body iron metabolism of s...

    Yutaka Kohgo, Katsuya Ikuta, Takaaki Ohtake in International Journal of Hematology (2008)

  17. No Access

    Article

    Combined Use of Dendritic Cells Enhances Specific Antileukemia Immunity by Leukemia Cell-Derived Heat Shock Protein 70 in a Mouse Model with Minimal Residual Leukemia Cells

    We have reported that immunotherapy using leukemia cell-derived heat shock proteins (HSPs) is effective against minimal residual disease (MRD) after syngeneic stem cell transplantation (SCT) in mice. However, ...

    Yasuyuki Iuchi, Yoshihiro Torimoto, Kazuya Sato in International Journal of Hematology (2006)

  18. No Access

    Article

    Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia

    Secondary clonal hematological disease in donor cells has rarely been reported as a complication of allogeneic stem cell transplantation in hematological disease. We report a case of myelodysplastic syndrome t...

    Satoshi Hashino, Fumie Fujisawa, Takeshi Kondo in International Journal of Hematology (2006)

  19. No Access

    Article

    Severe Hepatic Injury Caused by Imatinib Mesylate Administered for the Treatment of Chronic Myeloid Leukemia and the Efficacy of Prednisolone for its Management

    Imatinib mesylate is a specific inhibitor of BCR-ABL tyrosine kinase, which is now widely used for the treatment of chronic myeloid leukemia (CML) with a high efficacy. Although severe hepatic injury caused by...

    Katsuya Ikuta, Yoshihiro Torimoto, Junko Jimbo in International Journal of Hematology (2005)

  20. No Access

    Article

    Transferrin Receptor in Tissue and Serum: Updated Clinical Significance of Soluble Receptor

    The transferrin receptor is an essential component of cellular uptake of iron, and it binds to serum transferrin. Recently, 2 different types of transferrin receptors have been recognized: transferrin receptor...

    Yutaka Kohgo, Yoshihiro Torimoto, Junji Kato in International Journal of Hematology (2002)

previous disabled Page of 2